DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Lusedra is a drug marketed by Eisai Inc and is included in one NDA. There is one patent protecting this drug.
This drug has thirty-four patent family members in twenty-five countries.
The generic ingredient in LUSEDRA is fospropofol disodium. Additional details are available on the fospropofol disodium profile page.
Lusedra was eligible for patent challenges on December 12, 2012.
By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be July 1, 2022. This may change due to patent challenges or generic licensing.
Indicators of Generic Entry
DrugPatentWatch® Estimated Generic Entry Opportunity Date for LUSEDRA
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for LUSEDRA
Identify potential brand extensions & 505(b)(2) entrants
|Grace Shih, MD||N/A|
|Mayo Clinic||Phase 4|
|Eisai Inc.||Phase 1|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Eisai Inc||LUSEDRA||fospropofol disodium||SOLUTION;INTRAVENOUS||022244-001||Dec 12, 2008||DISCN||No||No||Get Started for $10||Get Started for $10||Y||Y||Get Started for $10|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Patent No.||Patent Expiration|
|Eisai Inc||LUSEDRA||fospropofol disodium||SOLUTION;INTRAVENOUS||022244-001||Dec 12, 2008||Get Started for $10||Get Started for $10|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>Patent No.||>Patent Expiration|